ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Aripiprazole

Also written as “aripiprazole”, “Aripiprazole IM Depot” and “Antidepressant + Aripiprazole”.

Its studies are mostly in Schizophrenia · Bipolar Disorder · Depressive Disorder, Major · Tourette Syndrome · Autistic Disorder, led by 10 companies.

Drug pageAripiprazole: every studyMany companies study it; this page follows only the 124 they lead. All 292 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Mar 26, 2004124 company-led studies, 1 open or runningNext primary completion: Sep 5, 2027

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Otsuka1120 open or runningphase 4since Mar 26, 2004May 7, 2002none ahead
Johnson & Johnsonits history only40 open or runningphase 4since Feb 10, 2012Feb 10, 2012none ahead
Abdi İbrahim Otsukaits history only10 open or runningphase 4since Feb 23, 2016Feb 23, 2016none ahead
Chengdu Kanghong Pharmaceutical Groupits history only10 open or runningno phasesince Jul 24, 2017Jul 24, 2017none ahead
CMG Pharmaceuticalits history only10 open or runningphase 1since Jun 4, 2015Jun 4, 2015none ahead
CSPC Pharmaceutical Groupits history only11 open or runningno phasesince Mar 23, 2026Mar 23, 2026Sep 5, 2027NCT07547384
Genovate Biotechnologyits history only10 open or runningphase 4since Oct 8, 2007Oct 8, 2007none ahead
Genuine Research Center, Egyptits history only10 open or runningphase 1since Mar 27, 2023Mar 27, 2023none ahead
GlaxoSmithKlineits history only10 open or runningphase 1since Aug 18, 2011Aug 18, 2011none ahead
H. Lundbeckits history only10 open or runningphase 3since Oct 7, 2013Oct 7, 2013none ahead

Also a collaborator on its studies: PRA Health Sciences, Covance and Pfizer.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Otsuka only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 44 studies since Jan 19, 2008.

  1. Aug 18, 2014Phase 1 study in SchizophreniaNCT02220712 · 17 enrolled · Japan
  2. Apr 15, 2015Phase 3 study in SchizophreniaNCT02435836 · 631 enrolled
  3. Mar 13, 2016Phase 2 study in SchizophreniaNCT02722967 · 49 enrolled · United States
  4. May 2, 20172 phase 1 studies in SchizophreniaNCT03150771, NCT03287505
  5. May 11, 2017Phase 3 study in SchizophreniaNCT03172871 · 436 enrolled · China
  6. Sep 11, 2017Phase 1 study in SchizophreniaNCT03285503 · 12 enrolled · China
  7. Dec 13, 2017Phase 4 study in SchizophreniaNCT03376763 · 201 enrolled · Korea, Republic of
  8. Mar 27, 20182 phase 3 studiesNCT03487783, NCT03487770
  9. May 25, 2018Phase 4 study in SchizophreniaNCT03568500 · 44 enrolled · United Kingdom
  10. Sep 5, 2018Phase 4 study in Tourette SyndromeNCT03661983 · 36 enrolled · United States, Canada, Hungary
  11. Feb 12, 2019Phase 1 study in SchizophreniaNCT03854409 · 72 enrolled · United States
  12. Mar 21, 2019Phase 3 study in SchizophreniaNCT03892889 · 277 enrolled · United States
  13. Jul 19, 2019Phase 2 study in SchizophreniaNCT04030143 · 266 enrolled · United States
  14. Mar 29, 2024No phase study in Mental DisordersNCT06372210 · 54 enrolled · United States

TargetBeta

“Dopamine D2 receptor partial agonist; Serotonin 1a (5-HT1a) receptor partial agonist; Serotonin 2a (5-HT2a) receptor antagonist”ChEMBL 37, by rule

Other programs on the same three targets

ProgramCompanyFurthest phaseStudies
brexpiprazoleruleOtsukaphase 470

Studies

The newest 60 of 112 Otsuka leads. Each opens its study page. Every study on its drug page →

StudyPhaseStatusPrimary completionSize
NCT06372210Mental Disorders · United States–CompletedJul 19, 202354
NCT04030143Schizophrenia · United States2CompletedJul 8, 2020266
NCT03892889Schizophrenia · United States3TerminatedAug 12, 2020277
NCT03854409Schizophrenia · United States1CompletedApr 5, 201972
NCT03661983Tourette Syndrome · United States, Canada, Hungary4TerminatedJun 30, 202036
NCT03568500Schizophrenia · United Kingdom4CompletedMay 21, 201944
NCT03487783Tourette Syndrome · China3CompletedFeb 14, 2020121
NCT03487770Autistic Disorder · China3CompletedApr 21, 2020111
NCT03376763Schizophrenia · Korea, Republic of4CompletedNov 19, 2021201
NCT03285503Schizophrenia · China1CompletedOct 14, 201912
NCT03287505Schizophrenia · China1CompletedNov 8, 201924
NCT03172871Schizophrenia · China3CompletedJul 22, 2019436
NCT03150771Schizophrenia · United States1CompletedApr 18, 201836
NCT02722967Schizophrenia · United States2CompletedSep 201649
NCT02435836Schizophrenia3TerminatedDec 2012631
NCT02220712Schizophrenia · Japan1CompletedApr 201517
NCT02091882Device Latency · United States4CompletedApr 18, 201430
NCT02054702Schizophrenia3CompletedJun 201497
NCT01981811Schizophrenia · United States2WithdrawnMay 20140
NCT01942161Schizophrenia · Japan3CompletedNov 2014106
NCT01942148Schizophrenia · Japan3CompletedNov 201568
NCT01909466Schizophrenia · United States1CompletedMar 2014141
NCT01870999Schizophrenia · United States1CompletedOct 200841
NCT01727713Tourette Syndrome · United States, Canada, Hungary and more3CompletedAug 2014110
NCT01727700Tourette Syndrome · United States, Canada, Germany and more3CompletedAug 2013133
NCT01710709Bipolar I · United States, Canada, France and more3CompletedNov 2016748
NCT01683058Schizophrenia · United States, Croatia, Latvia3CompletedFeb 201474
NCT01663532Schizophrenia · United States, Croatia, Latvia3CompletedAug 2013340
NCT01646827Schizophrenia · United States1CompletedApr 201337
NCT01617460Autistic Disorder · Japan3CompletedOct 201686
NCT01617447Autistic Disorder · Japan3CompletedJun 201592
NCT01552772Schizophrenia · United States1CompletedApr 201260
NCT01509053Schizophrenia · Belgium, Bulgaria, Canada3TerminatedOct 201230
NCT01432444Schizophrenia · United States, Canada3CompletedDec 2013493
NCT01438060Alzheimer Disease3CompletedJul 2010232
NCT01429831Depressive Disorder, Major · Taiwan4CompletedMay 2013300
NCT01418352Tourette Syndrome · United States, Bulgaria, Germany and more3CompletedMar 12, 201483
NCT01418339Tourette Syndrome · United States, Canada, Hungary and more3CompletedNov 6, 2013135
NCT01416441Tourette Syndrome · United States, Bulgaria, Canada and more3CompletedMar 13, 2014170
NCT01227668Irritability Associated With Autistic Disorder · United States4CompletedJun 20, 2012215
NCT01149655Schizophrenia · United States, India, Malaysia and more3CompletedNov 2013252
NCT01129882Schizophrenia · United States, Argentina, Australia and more3CompletedDec 6, 2018709
NCT01123707Depressive Disorder, Major3TerminatedSep 27, 2011173
NCT01122927Mania · United States, Bulgaria, Croatia and more3TerminatedAug 2014524
NCT01111565Depressive Disorder, Major · United States, Canada, Croatia and more3TerminatedSep 1, 2011137
NCT01111552Depressive Disorder, Major · United States, Australia, Bulgaria and more3TerminatedSep 27, 2011237
NCT01111539Depressive Disorder, Major · United States, Estonia, Finland and more3TerminatedSep 20, 2011211
NCT01001702Schizophrenia · Argentina, Croatia, India and more3CompletedJul 201285
NCT00882362Depressive Disorder, Major · Japan3CompletedJul 2012155
NCT00876343Depressive Disorder, Major · Japan3CompletedJul 2012586
NCT00857818Schizophrenia · Canada3TerminatedMar 201064
NCT00731549Schizophrenia · United States, Argentina, Australia and more3CompletedNov 20131,081
NCT00712686Schizophrenia3CompletedDec 2003690
NCT00706654Schizophrenia · United States, Austria, Belgium and more3CompletedAug 1, 2012937
NCT00706589Tic Disorders · Korea, Republic of3CompletedApr 201061
NCT00705783Schizophrenia · United States, Argentina, Bulgaria and more3CompletedAug 2010843
NCT00665366Bipolar Disorder Mania · Austria, Czech Republic, France and more3CompletedOct 2011493
NCT00606320Bipolar I Disorder · China, Japan, Korea, Republic of and more3CompletedNov 201059
NCT00606281Bipolar I Disorder · China, Japan, Korea, Republic of and more3CompletedNov 2010258
NCT00606229Bipolar I Disorder · Japan3CompletedNov 201041

How it is read

Names in the registry

  • “Aripiprazole”, 81 entries
  • “aripiprazole”, 13 entries
  • “Aripiprazole IM Depot”, 7 entries
  • “Antidepressant + Aripiprazole”, 2 entries
  • “Aripiprazole for Injection”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.